Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short Course Alendronate to Prevent BMD Loss in HIV
NCT02322099Phase 4Terminated
- Sponsor
- University College Dublin
- Start
- May 2016
- Primary completion
- Sep 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of alendronate in bone demineralization, sponsored by University College Dublin. Started May 2016; status: terminated.
02
Drugs
alendronate
03
Conditions
bone demineralization
Beyond the preview
Go deeper on NCT02322099.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02322099.